Aptargroup (ATR) Non Operating Investment Income (2020 - 2026)
Aptargroup (ATR) reported Non Operating Investment Income of -$1.1 million for Q1 2026, up 0.91% year-over-year from -$1.1 million in Q1 2025, and up 18.22% quarter-over-quarter from -$1.3 million in Q4 2025.
Aptargroup (ATR) Non Operating Investment Income (2020 - 2026) Analysis & Trends
Aptargroup (ATR) has 7 years of Non Operating Investment Income data on file, last reported at -$1.1 million in Q1 2026.
- Non Operating Investment Income for Q1 2026 came in at -$1.1 million, up 0.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$473000.0 (down 1992.0% YoY), and the FY2025 annual result was -$483000.0, down 128.2% from the prior year.
- Non Operating Investment Income climbed to -$1.1 million in Q1 2026 per ATR's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $2.9 million in Q2 2023 and troughed at -$1.3 million in Q4 2025.
- A 5-year average of -$32529.4 and a median of -$161000.0 in 2025 frame the typical range for Non Operating Investment Income.
- On a YoY basis, Non Operating Investment Income climbed as much as 1601.43% in 2025 and fell as far as 709.17% in 2025.
- A 5-year view of Non Operating Investment Income shows it stood at -$1.0 million in 2022, then soared by 58.48% to -$426000.0 in 2023, then surged by 151.17% to $218000.0 in 2024, then tumbled by 709.17% to -$1.3 million in 2025, then advanced by 18.22% to -$1.1 million in 2026.
- Business Quant data shows ATR's Non Operating Investment Income at -$1.1 million in Q1 2026, -$1.3 million in Q4 2025, and -$161000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09 Mn |
| Mar 31, 2026 | -1.09 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | -161,000.00 |
| Sep 30, 2025 | -161,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | -1.10 Mn |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | 218,000.00 |
| Dec 31, 2024 | 218,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -140,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | -426,000.00 |
| Dec 31, 2023 | -426,000.00 |